1. Home
  2. VRAX vs GURE Comparison

VRAX vs GURE Comparison

Compare VRAX & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • GURE
  • Stock Information
  • Founded
  • VRAX 2013
  • GURE 2006
  • Country
  • VRAX United Kingdom
  • GURE China
  • Employees
  • VRAX N/A
  • GURE N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GURE Major Chemicals
  • Sector
  • VRAX Health Care
  • GURE Industrials
  • Exchange
  • VRAX Nasdaq
  • GURE Nasdaq
  • Market Cap
  • VRAX 7.3M
  • GURE 7.1M
  • IPO Year
  • VRAX 2022
  • GURE 1992
  • Fundamental
  • Price
  • VRAX $1.66
  • GURE $0.69
  • Analyst Decision
  • VRAX
  • GURE
  • Analyst Count
  • VRAX 0
  • GURE 0
  • Target Price
  • VRAX N/A
  • GURE N/A
  • AVG Volume (30 Days)
  • VRAX 236.4K
  • GURE 225.3K
  • Earning Date
  • VRAX 02-05-2025
  • GURE 11-19-2024
  • Dividend Yield
  • VRAX N/A
  • GURE N/A
  • EPS Growth
  • VRAX N/A
  • GURE N/A
  • EPS
  • VRAX N/A
  • GURE N/A
  • Revenue
  • VRAX $84,872.00
  • GURE $12,802,982.00
  • Revenue This Year
  • VRAX $5,169.18
  • GURE N/A
  • Revenue Next Year
  • VRAX $66.97
  • GURE N/A
  • P/E Ratio
  • VRAX N/A
  • GURE N/A
  • Revenue Growth
  • VRAX 7.03
  • GURE N/A
  • 52 Week Low
  • VRAX $0.60
  • GURE $0.50
  • 52 Week High
  • VRAX $9.00
  • GURE $1.79
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 42.25
  • GURE 54.17
  • Support Level
  • VRAX $1.56
  • GURE $0.61
  • Resistance Level
  • VRAX $1.86
  • GURE $0.73
  • Average True Range (ATR)
  • VRAX 0.19
  • GURE 0.08
  • MACD
  • VRAX -0.04
  • GURE -0.00
  • Stochastic Oscillator
  • VRAX 26.31
  • GURE 52.94

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: